Flolipid
Product Images NDC 29273-401

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Flolipid (NDC 29273-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Salerno Pharmaceuticals Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Simvastatin 20mg.jpg (Flolipid 20mg Carton)

Packaging label for FloLipid simvastatin 20 mg/5 mL oral suspension, 150 mL bottle. The label features purple and turquoise text and design elements on a light purple background. It includes dosage information, drug facts, manufacturer details, storage instructions, and a barcode. Labeler is Salerno Pharmaceuticals Co.*

FDA Label Image

Simvastatin 20mg.jpg (Flolipid 20mg Label)

FloLipid 20 mg/5 mL oral suspension label showing the active ingredient simvastatin. The label includes dosage information, storage instructions, manufacturer details (Rosemont Pharmaceuticals Ltd., UK), and the labeler Salerno Pharmaceuticals Co. The net content is 150 mL. The label also cautions to shake well before use and discard 30 days after opening.*

FDA Label Image

Simvastatin 20mg.jpg (Flolipid 40mg Carton)

Packaging label for FloLipid simvastatin oral suspension, 40 mg per 5 mL, in a 150 mL bottle. Label indicates the product is an oral suspension with strawberry flavor, manufactured by Salerno Pharmaceuticals Co. Directions and storage instructions are included. The label features blue and purple color accents with a wave design.*

FDA Label Image

Simvastatin 40mg (Flolipid 40mg Label)

Label for FloLipid simvastatin oral suspension, 40 mg/5 mL. The label states the product is for oral use only, with a 150 mL net content and a requirement to discard 30 days after opening. It includes storage instructions, a list of inactive ingredients, and manufacturing information indicating Rosemont Pharmaceuticals Ltd. UK as the manufacturer and Salerno Pharmaceuticals LP as the labeler.*

FDA Label Image

Figure 1 (Flolipid Fig1)

A forest plot graph showing the effects of treatment with Simvastatin on major vascular and coronary events, stratified by baseline characteristics such as presence of CHD, diabetes, gender, age, LDL, and HDL cholesterol levels. The risk ratios with confidence intervals for simvastatin and placebo groups are displayed, indicating the comparative incidence and favorability between treatments.*

FDA Label Image

Chemical Structure (Flolipid Str)

Chemical structure of the active ingredient for FloLipid, showing a steroid-like molecular framework with multiple rings, hydroxyl, ketone, and methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.